LMLori Mosca

Lori Mosca

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lori Mosca has a total of 99 co-authors. Here are the top co-authors by number of shared publications:

  • Heidi Mochari-Greenberger

    AbleTo, Inc New York, NY United States

    19 shared publications
  • Brooke Aggarwal

    Heidi Mochari-Greenberger, PhD, MPH Postdoctoral Research Fellow, Department of Medicine, Columbia University Medical Center, New York

    7 shared publications
  • Allison H. Christian

    Columbia University Medical Center/New York-Presbyterian Hospital, New York, New York

    6 shared publications
  • Ming Liao

    Department of Medicine, Columbia University Medical Center, New York, New York

    6 shared publications
  • Elizabeth Barrett-Connor

    From the Columbia University Medical Center, New York, NY (L.M.); University of California San Diego School of Medicine, La Jolla (E.B.-C.); and Emory University School of Medicine, Atlanta, GA (N.K.W.).

    3 shared publications
  • Furcy Paultre

    Department of Medicine, Columbia University, New York, New York

    3 shared publications

Latest Publications

  • Reducing Cardiovascular Disease Risk in Women Beyond Statin Therapy: New Insights 2020

    by Lori Mosca, Ann Marie Navar, Nanette Kass Wenger

    Management of residual and persistent cardiovascular disease (CVD) risk among statin-treated individuals has emerged as an important preventive strategy. The purpose of this article is to review the unique landscape of CVD in women and relevant prior prevention trials, and to discuss how the recent results of the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT) might apply to the contemporary management of CVD risk among statin-treated women. Women have unique risk factors that may impact CVD and its prevention. Historically, women have been underrepresented in CVD trials, posing a challenge to development of clinical recommendations for women. Low-density lipoprotein cholesterol-targeting treatments have demonstrated CVD risk reduction, with comparable effects in both sexes. In contrast, triglyceride-lowering treatments (niacin, fenofibrate, and omega-3 fatty acids) have reported mixed findings for CVD risk reduction. Recent clinical trials of combination omega-3 fatty acids (docosahexaenoic acid/eicosapentaenoic acid [EPA]) have not found significant CVD risk reduction. The recently published REDUCE-IT study found that icosapent ethyl, an EPA-only omega-3 fatty acid, in combination with statins, significantly reduced CVD events in high-risk patients. The icosapent ethyl group had a significantly lower occurrence of the primary composite CVD endpoint (17.2%) than the placebo group (22.0%; hazard ratio 0.75; 95% confidence interval 0.68–0.83; p < 0.001). CVD risk reduction with icosapent ethyl treatment was comparable between women and men (p for interaction, 0.33). Data from REDUCE-IT suggest women benefit similarly to men with respect to icosapent ethyl, a novel therapy for prevention of CVD.


  • Open Access

    Usefulness of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women to Lower Triglyceride Levels (Results from the MARINE and ANCHOR Trials)

    by Lori Mosca, Christie M. Ballantyne, Harold E. Bays, John R. Guyton, Sephy Philip, Ralph T. Doyle, Rebecca A. Juliano


  • National Women’s Knowledge of Stroke Warning Signs, Overall and by Race/Ethnic Group

    by Heidi Mochari-Greenberger, Amytis Towfighi, Lori Mosca

    Background and Purpose—: Recognition of stroke warning signs may reduce treatment delays. The purpose of this study was to evaluate contemporary knowledge of stroke warning signs and knowledge to call 9-1-1, among a nationally representative sample of women, overall and by race/ethnic group. Methods—: A study of cardiovascular disease awareness was conducted by the American Heart Association in 2012 among English-speaking US women ≥25 years identified through random-digit dialing (n=1205; 54% white, 17% black, 17% Hispanic, and 12% other). Knowledge of stroke warning signs, and what to do first if experiencing stroke warning signs, was assessed by standardized open-ended questions. Results—: Half of women surveyed (51%) identified sudden weakness/numbness of face/limb on one side as a stroke warning sign; this did not vary by race/ethnic group. Loss of/trouble talking/understanding speech was identified by 44% of women, more frequently among white versus Hispanic women (48% versus 36%; P <0.05). Fewer than 1 in 4 women identified sudden severe headache (23%), unexplained dizziness (20%), or sudden dimness/loss of vision (18%) as warning signs, and 1 in 5 (20%) did not know 1 stroke warning sign. The majority of women said that they would call 9-1-1 first if they thought they were experiencing signs of a stroke (84%), and this did not vary among black (86%), Hispanic (79%), or white/other (85%) women. Conclusions—: Knowledge of stroke warning signs was low among a nationally representative sample of women, especially among Hispanics. In contrast, knowledge to call 9-1-1 when experiencing signs of stroke was high.


  • Caregiver Status

    by Heidi Mochari-Greenberger, Matthew Ba Mosca, Brooke Aggarwal, Tianna M. Pa-C Umann, Lori Mosca

    Background: Patients who have undergone cardiac surgery, especially those with greater comorbidities, may be cared for by family members or paid aides. Objective: The purpose of this study was to evaluate the association between having a caregiver among patients who underwent cardiac surgery and clinical outcomes at 1 year. We hypothesized that patients with a caregiver would have longer lengths of stay and higher rehospitalization or death rates 1 year after surgery. Methods: We studied 665 patients consecutively admitted for cardiac surgery as part of the Family Cardiac Caregiver Investigation To Evaluate Outcomes sponsored by the National Heart, Lung, and Blood Institute. The participants (mean age, 65 years; women, 35%; racial/ethnic minorities, 21%) completed an interviewer-assisted questionnaire to determine caregiver status. Outcomes were documented by a hospital-based information system; demographics/comorbidities, by electronic records. Associations between having a caregiver and outcomes were evaluated by logistic regression, adjusted for demographic and comorbid conditions. Results: At baseline, 28% of the patients (n = 183) had a caregiver (8%, paid; 20%, informal only). Having a caregiver was associated with longer (>7 days) postoperative length of stay in univariate analysis among the patients with paid (odds ratio [OR], 3.00; 95% confidence interval [CI], 1.57–5.74) or informal (OR, 1.55; 95% CI, 1.04–2.31) caregivers versus none; the association remained significant for the patients with paid (OR, 2.13; 95% CI, 1.00–4.55) but not with informal (OR, 1.12; 95% CI, 0.70–1.80) caregivers after adjustment. Having a paid caregiver was significantly associated with rehospitalization/death at 1 year in univariate analysis (OR, 2.09; 95% CI, 1.18–3.69); having an informal caregiver was not (OR, 1.39; 95% CI, 0.94–2.06). Increased odds of rehospitalization/death associated with having a paid caregiver attenuated after adjustment (OR, 1.39; 95% CI, 0.74–2.62). Conclusions: The patients who underwent cardiac surgery who had a paid caregiver had a significantly longer length of stay independent of comorbidity. The increased risk of rehospitalization/death associated with having a paid caregiver was explained by demographics and comorbidity. These data suggest that caregiver status assessment may be a simple method to identify cardiac surgery patients at increased risk for adverse clinical outcomes.


  • Medication Adherence Is Associated with Having a Caregiver Among Cardiac Patients

    by Brooke Aggarwal, Ming Liao, Lori Mosca

    Background. Medication non-adherence is a significant contributor to suboptimal control of blood pressure and lipids.Purpose. This study determined if


  • Open Access

    Caregiver Burden and Nonachievement of Healthy Lifestyle Behaviors among Family Caregivers of Cardiovascular Disease Patients

    by Heidi Mochari-Greenberger, Lori Mosca

    Purpose.: To determine whether caregiver burdens are associated with lifestyle behaviors 1 year following the hospitalization of a family member with cardiovascular disease (CVD). Design.: Prospective follow-up study of National Heart Lung and Blood Institute sponsored Family Intervention Trial for Heart Health participants. Setting.: Hospital-based recruitment/baseline visit with 1-year follow-up. Subjects.: Family members of hospitalized CVD patients (N = 423; 67% female; 36% racial/ethnic minority; mean age 49 years). Measures.: Systematic evaluation at 1 year to determine heart-healthy diet (defined as <10% kcal from saturated fat; Block 98 Food Frequency Questionnaire) and physical activity (defined as ≥4d/wk; Behavioral Risk Factor Surveillance System Survey) behaviors and caregiver burdens (five domains: employment, financial, physical, social, and time; Caregiver Strain Questionnaire). Analysis.: Logistic regression adjusted for covariates. Results.: Heart-healthy diet was less frequent among caregivers citing feeling overwhelmed (odds ratio [OR] = .50; 95% confidence interval [CI] = .26–.97), sleep disturbance (OR = .51; 95% CI = .27–.96), financial strain (OR = .41; 95% CI = .20–.86), upsetting behavior (OR = .48; 95% CI = .25–.92), and/or time demands (OR = .47; 95% CI = .26–.85) as burdens. Physical activity was less frequent among caregivers reporting financial strain (OR = .32; 95% CI = .13–.81) or upsetting patient behavior (OR = .33; 95% CI = .15–.76) as burdens. The most commonly cited caregiver burdens included changes in personal plans (39%), time demands (38%), and sleep disturbance (30%). Conclusion.: Caregiver burdens were associated with nonachievement of heart-healthy diet and physical activity behaviors among family caregivers 1 year after patient discharge. When developing heart-health promotion interventions, caregiver burden should be considered as a possible barrier to prevention among family members of CVD patients.